SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Watkins H) "

Search: WFRF:(Watkins H)

  • Result 641-650 of 680
Sort/group result
   
EnumerationReferenceCoverFind
641.
  •  
642.
  • Hysell, D. L., et al. (author)
  • Heater-induced ionization inferred from spectrometric airglow measurements
  • 2014
  • In: Journal of Geophysical Research A: Space Physics. - 2169-9380. ; 119:3, s. 2038-2045
  • Journal article (peer-reviewed)abstract
    • Spectrographic airglow measurements were made during an ionospheric modification experiment at High Frequency Active Auroral Research Program on 12 March 2013. Artificial airglow enhancements at 427.8, 557.7, 630.0, 777.4, and 844.6 nm were observed. On the basis of these emissions and using a methodology based on the method of Backus and Gilbert (1968, 1970), we estimate the suprathermal electron population and the subsequent equilibrium electron density profile, including contributions from electron impact ionization. We find that the airglow is consistent with heater-induced ionization in view of the spatial intermittency of the airglow.
  •  
643.
  • Jarvis, Debbie, et al. (author)
  • Prevalence of asthma-like symptoms with ageing
  • 2018
  • In: Thorax. - : BMJ Publishing Group Ltd. - 0040-6376 .- 1468-3296. ; 73:1, s. 37-48
  • Journal article (peer-reviewed)abstract
    • BACKGROUND: Change in the prevalence of asthma-like symptoms in populations of ageing adults is likely to be influenced by smoking, asthma treatment and atopy.METHODS: The European Community Respiratory Health Survey collected information on prevalent asthma-like symptoms from representative samples of adults aged 20-44 years (29 centres in 13 European countries and Australia) at baseline and 10 and 20 years later (n=7844). Net changes in symptom prevalence were determined using generalised estimating equations (accounting for non-response through inverse probability weighting), followed by meta-analysis of centre level estimates.FINDINGS: Over 20 years the prevalence of 'wheeze' and 'wheeze in the absence of a cold' decreased (-2.4%, 95% CI -3.5 to -1.3%; -1.5%, 95% CI -2.4 to -0.6%, respectively) but the prevalence of asthma attacks, use of asthma medication and hay fever/nasal allergies increased (0.6%, 95% CI 0.1 to 1.11; 3.6%, 95% CI 3.0 to 4.2; 2.7%, 95% CI 1.7 to 3.7). Changes were similar in the first 10 years compared with the second 10 years, except for hay fever/nasal allergies (increase seen in the first 10 years only). Decreases in these wheeze-related symptoms were largely seen in the group who gave up smoking, and were seen in those who reported hay fever/nasal allergies at baseline.INTERPRETATION: European adults born between 1946 and 1970 have, over the last 20 years, experienced less wheeze, although they were more likely to report asthma attacks, use of asthma medication and hay fever. Decrease in wheeze is largely attributable to smoking cessation, rather than improved treatment of asthma. It may also be influenced by reductions in atopy with ageing.
  •  
644.
  •  
645.
  •  
646.
  • Kitaba, N. T., et al. (author)
  • Fathers' preconception smoking and offspring DNA methylation
  • 2023
  • In: Clinical Epigenetics. - : BioMed Central (BMC). - 1868-7075 .- 1868-7083. ; 15:1
  • Journal article (peer-reviewed)abstract
    • Background Experimental studies suggest that exposures may impact respiratory health across generations via epigenetic changes transmitted specifically through male germ cells. Studies in humans are, however, limited. We aim to identify epigenetic marks in offspring associated with father's preconception smoking.Methods We conducted epigenome-wide association studies (EWAS) in the RHINESSA cohort (7-50 years) on father's any preconception smoking (n = 875 offspring) and father's pubertal onset smoking < 15 years (n = 304), using Infinium MethylationEPIC Beadchip arrays, adjusting for offspring age, own smoking and maternal smoking. EWAS of maternal and offspring personal smoking were performed for comparison. Father's smoking-associated dmCpGs were checked in subpopulations of offspring who reported no personal smoking and no maternal smoking exposure.Results Father's smoking commencing preconception was associated with methylation of blood DNA in offspring at two cytosine-phosphate-guanine sites (CpGs) (false discovery rate (FDR) < 0.05) in PRR5 and CENPP. Father's pubertal onset smoking was associated with 19 CpGs (FDR < 0.05) mapped to 14 genes (TLR9, DNTT, FAM53B, NCAPG2, PSTPIP2, MBIP, C2orf39, NTRK2, DNAJC14, CDO1, PRAP1, TPCN1, IRS1 and CSF1R). These differentially methylated sites were hypermethylated and associated with promoter regions capable of gene silencing. Some of these sites were associated with offspring outcomes in this cohort including ever-asthma (NTRK2), ever-wheezing (DNAJC14, TPCN1), weight (FAM53B, NTRK2) and BMI (FAM53B, NTRK2) (p < 0.05). Pathway analysis showed enrichment for gene ontology pathways including regulation of gene expression, inflammation and innate immune responses. Father's smoking-associated sites did not overlap with dmCpGs identified in EWAS of personal and maternal smoking (FDR < 0.05), and all sites remained significant (p < 0.05) in analyses of offspring with no personal smoking and no maternal smoking exposure.Conclusion Father's preconception smoking, particularly in puberty, is associated with offspring DNA methylation, providing evidence that epigenetic mechanisms may underlie epidemiological observations that pubertal paternal smoking increases risk of offspring asthma, low lung function and obesity.
  •  
647.
  • Kolz, Melanie, et al. (author)
  • Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations
  • 2009
  • In: PLoS genetics. - : Public Library of Science (PLoS). - 1553-7404. ; 5:6, s. e1000504-
  • Journal article (peer-reviewed)abstract
    • Elevated serum uric acid levels cause gout and are a risk factor for cardiovascular disease and diabetes. To investigate the polygenetic basis of serum uric acid levels, we conducted a meta-analysis of genome-wide association scans from 14 studies totalling 28,141 participants of European descent, resulting in identification of 954 SNPs distributed across nine loci that exceeded the threshold of genome-wide significance, five of which are novel. Overall, the common variants associated with serum uric acid levels fall in the following nine regions: SLC2A9 (p = 5.2×10−201), ABCG2 (p = 3.1×10−26), SLC17A1 (p = 3.0×10−14), SLC22A11 (p = 6.7×10−14), SLC22A12 (p = 2.0×10−9), SLC16A9 (p = 1.1×10−8), GCKR (p = 1.4×10−9), LRRC16A (p = 8.5×10−9), and near PDZK1 (p = 2.7×10−9). Identified variants were analyzed for gender differences. We found that the minor allele for rs734553 in SLC2A9 has greater influence in lowering uric acid levels in women and the minor allele of rs2231142 in ABCG2 elevates uric acid levels more strongly in men compared to women. To further characterize the identified variants, we analyzed their association with a panel of metabolites. rs12356193 within SLC16A9 was associated with DL-carnitine (p = 4.0×10−26) and propionyl-L-carnitine (p = 5.0×10−8) concentrations, which in turn were associated with serum UA levels (p = 1.4×10−57 and p = 8.1×10−54, respectively), forming a triangle between SNP, metabolites, and UA levels. Taken together, these associations highlight additional pathways that are important in the regulation of serum uric acid levels and point toward novel potential targets for pharmacological intervention to prevent or treat hyperuricemia. In addition, these findings strongly support the hypothesis that transport proteins are key in regulating serum uric acid levels.
  •  
648.
  •  
649.
  • Mikus, Maria, et al. (author)
  • Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury
  • 2016
  • In: Liver international. - : John Wiley & Sons. - 1478-3223 .- 1478-3231. ; 37:1, s. 132-140
  • Journal article (peer-reviewed)abstract
    • Background & Aims: The occurrence of drug-induced liver injury (DILI) is a major issue in all phases of drug development. To identify novel biomarker candidates associated with DILI, we utilised an affinity proteomics strategy, where antibody suspension bead arrays were applied to profile plasma and serum samples from human DILI cases and controls. Methods: An initial screening was performed using 4594 randomly selected antibodies, representing 3450 human proteins. Resulting candidate proteins together with proposed DILI biomarker candidates generated a DILI array of 251 proteins for subsequent target analysis and verifications. In total, 1196 samples from 241 individuals across four independent cohorts were profiled: healthy volunteers receiving acetaminophen, patients with human immunodeficiency virus and/or tuberculosis receiving treatment, DILI cases originating from a wide spectrum of drugs, and healthy volunteers receiving heparins. Results: We observed elevated levels of cadherin 5, type 2 (CDH5) and fatty acid-binding protein 1 (FABP1) in DILI cases. In the two longitudinal cohorts, CDH5 was elevated already at baseline. FABP1 was elevated after treatment initiation and seemed to respond more rapidly than alanine aminotransferase (ALT). The elevations were verified in the DILI cases treated with various drugs. In the heparin cohort, CDH5 was stable over time whereas FABP1 was elevated. Conclusions: These results suggest that CDH5 may have value as a susceptibility marker for DILI. FABP1 was identified as a biomarker candidate with superior characteristics regarding tissue distribution and kinetics compared to ALT but likely with limited predictive value for the development of severe DILI. Further studies are needed to determine the clinical utility of the proposed markers.
  •  
650.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 641-650 of 680
Type of publication
journal article (535)
conference paper (11)
research review (4)
Type of content
peer-reviewed (653)
other academic/artistic (17)
Author/Editor
Jones, G. (489)
Esposito, B. (488)
Price, D. (487)
Erdmann, J. (481)
Liu, Y. (469)
Chen, X. (465)
show more...
Kobayashi, T. (465)
Blumenschein, U. (464)
Cranmer, K. (464)
Etzion, E. (464)
Garcia, C. (464)
Hasegawa, Y. (464)
Hughes, G. (464)
Kawagoe, K. (464)
Kawamoto, T. (464)
Martin, B. (464)
Antonelli, M. (463)
Barklow, T. (463)
Bella, G. (463)
Benekos, N. (463)
Boonekamp, M. (463)
Calderini, G. (463)
Dallapiccola, C. (463)
Eigen, G. (463)
Fassouliotis, D. (463)
Ferrer, A. (463)
Fleck, I. (463)
Fukunaga, C. (463)
George, S. (463)
Gross, E. (463)
Hamacher, K. (463)
Hauser, R. (463)
Hill, J. C. (463)
Iwasaki, H. (463)
Kanaya, N. (463)
Kourkoumelis, C. (463)
Lellouch, D. (463)
Liebig, W. (463)
Lucotte, A. (463)
Macchiolo, A. (463)
Martinez, M. (463)
Masik, J. (463)
Meyer, J. (463)
Mikenberg, G. (463)
Mohr, W. (463)
Morii, M. (463)
Nagai, K. (463)
Okumura, Y. (463)
Ouraou, A. (463)
Pallin, D. (463)
show less...
University
Uppsala University (384)
Lund University (384)
Royal Institute of Technology (335)
Stockholm University (313)
Karolinska Institutet (127)
University of Gothenburg (43)
show more...
Umeå University (31)
Chalmers University of Technology (31)
Högskolan Dalarna (7)
Örebro University (3)
Linköping University (3)
Mid Sweden University (2)
Södertörn University (2)
Luleå University of Technology (1)
Stockholm School of Economics (1)
The Swedish School of Sport and Health Sciences (1)
Karlstad University (1)
Swedish University of Agricultural Sciences (1)
show less...
Language
English (680)
Research subject (UKÄ/SCB)
Natural sciences (376)
Medical and Health Sciences (104)
Engineering and Technology (15)
Social Sciences (2)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view